Dana-Farber ends 2017 with $36.8M operating loss

Boston-based Dana-Farber Cancer Institute ended 2017 with an operating loss of $36.8 million, compared to operating income of $29.7 million in the year prior.

Advertisement

Dana-Farber saw revenues increase 8.4 percent year over year to $1.52 billion in 2017, according to recently released bondholder documents. The hospital’s patient service revenue and research revenue grew 6 percent and 12.3 percent, respectively, year over year.

Higher expenses offset the hospital’s revenue gains. In 2017, Dana-Farber recorded operating expenses of $1.56 billion. That’s up from $1.38 billion in the year prior.

After factoring in strong investment gains, Dana-Farber ended 2017 with net income of $21.2 million, compared to $36.8 million in 2016.

More articles on healthcare finance:

Miami hospital files for bankruptcy: 4 things to know
Moody’s: Nursing shortage will pressure hospital margins for years
Wisconsin hospital at risk of losing Medicare contract over injuries to babies

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.